Igyxos
Nouzilly
About Igyxos
Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $15.2M
- Funding stage: Early Stage Venture
- Last round: Grant (Oct 2025)
- Website: igyxos.com
- Phone: + 33 2 47 42 79 57
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/igyxos-107407 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.